Overview

Early Administration of Ivabradine in Children With Heart Failure

Status:
Enrolling by invitation
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
This is a monocentric, prospective, single arm, not for profit study. It is designed to study the early use of ivabradine in patients with dilated cardiomyopathy and Ejection Fraction (EF) < 45%.
Phase:
Phase 2
Details
Lead Sponsor:
Bambino Gesù Hospital and Research Institute
Collaborator:
Ministero della Salute, Italy